Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Medical Condition: We want to investigate whether increased vasodilitation ( angiotensin converting enzyme inhibitor and calcium channel blocker) compared to standard treatment ( beta-blocker and angiotensin converting enzyme inhibitor) reduces the rate of decline of GFR in patients with chronic kidney disease (grade 3 to 4) and hypertension.Patients with ischemic heart disease or congestive heart failure will be treated with Carvedilol if randomized to increased Vasodilitation. MedDRA version: 13.1Level: LLTClassification code 10063097Term: Peripheral vasodilatationSystem Organ Class: 10047065 - Vascular disorders MedDRA version: 13.1Level: PTClassification code 10047141Term: VasodilatationSystem Organ Class: 10047065 - Vascular disorders;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+We+want+to+investigate+whether+increased+vasodilitation+%28+angiotensin+converting+enzyme+inhibitor+and+calcium+channel+blocker%29+compared+to+standard+treatment+%28+beta-blocker+and+angiotensin+converting+enzyme+inhibitor%29+reduces+the+rate+of+decline+of+GFR+in+patients+with+chronic+kidney+disease+%28grade+3+to+4%29+and+hypertension.Patients+with+ischemic+heart+disease+or+congestive+heart+failure+will+be+treated+with+Carvedilol+if+randomized+to+increased+Vasodilitation.+MedDRA+version%3A+13.1Level%3A+LLTClassification+code+10063097Term%3A+Peripheral+vasodilatationSystem+Organ+Class%3A+10047065+-+Vascular+disorders+MedDRA+version%3A+13.1Level%3A+PTClassification+code+10047141Term%3A+VasodilatationSystem+Organ+Class%3A+10047065+-+Vascular+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cardiovascular+Diseases+%5BC14%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22angiotensin-converting+enzyme+inhibitors%22&type0%5B%5D=Subject&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+We+want+to+investigate+whether+increased+vasodilitation+%28+angiotensin+converting+enzyme+inhibitor+and+calcium+channel+blocker%29+compared+to+standard+treatment+%28+beta-blocker+and+angiotensin+converting+enzyme+inhibitor%29+reduces+the+rate+of+decline+of+GFR+in+patients+with+chronic+kidney+disease+%28grade+3+to+4%29+and+hypertension.Patients+with+ischemic+heart+disease+or+congestive+heart+failure+will+be+treated+with+Carvedilol+if+randomized+to+increased+Vasodilitation.+MedDRA+version%3A+13.1Level%3A+LLTClassification+code+10063097Term%3A+Peripheral+vasodilatationSystem+Organ+Class%3A+10047065+-+Vascular+disorders+MedDRA+version%3A+13.1Level%3A+PTClassification+code+10047141Term%3A+VasodilatationSystem+Organ+Class%3A+10047065+-+Vascular+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cardiovascular+Diseases+%5BC14%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22angiotensin-converting+enzyme+inhibitors%22&type0%5B%5D=Subject&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+We+want+to+investigate+whether+increased+vasodilitation+%28+angiotensin+converting+enzyme+inhibitor+and+calcium+channel+blocker%29+compared+to+standard+treatment+%28+beta-blocker+and+angiotensin+converting+enzyme+inhibitor%29+reduces+the+rate+of+decline+of+GFR+in+patients+with+chronic+kidney+disease+%28grade+3+to+4%29+and+hypertension.Patients+with+ischemic+heart+disease+or+congestive+heart+failure+will+be+treated+with+Carvedilol+if+randomized+to+increased+Vasodilitation.+MedDRA+version%3A+13.1Level%3A+LLTClassification+code+10063097Term%3A+Peripheral+vasodilatationSystem+Organ+Class%3A+10047065+-+Vascular+disorders+MedDRA+version%3A+13.1Level%3A+PTClassification+code+10047141Term%3A+VasodilatationSystem+Organ+Class%3A+10047065+-+Vascular+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cardiovascular+Diseases+%5BC14%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22angiotensin-converting+enzyme+inhibitors%22&type0%5B%5D=Subject&op0%5B%5D=OR
PubPharm (2)
1
Role of renal and systemic vascular resistance for progression of chronic kidney disease - RenVas : Role of renal and systemic vascular resistance for progression of chronic kidney disease - RenVas
enthalten in:
WHO International Clinical Trials Registry Platform
| 2015
Wird geladen...
2
Role of renal and systemic vascular resistance for progression of chronic kidney disease - RenVas : Role of renal and systemic vascular resistance for progression of chronic kidney disease - RenVas
enthalten in:
WHO International Clinical Trials Registry Platform
| 2015
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: We want to investigate whether increased vasodilitation ( angiotensin converting enzyme inhibitor and calcium channel blocker) compared to standard treatment ( beta-blocker and angiotensin converting enzyme inhibitor) reduces the rate of decline of GFR in patients with chronic kidney disease (grade 3 to 4) and hypertension.Patients with ischemic heart disease or congestive heart failure will be treated with Carvedilol if randomized to increased Vasodilitation. MedDRA version: 13.1Level: LLTClassification code 10063097Term: Peripheral vasodilatationSystem Organ Class: 10047065 - Vascular disorders MedDRA version: 13.1Level: PTClassification code 10047141Term: VasodilatationSystem Organ Class: 10047065 - Vascular disorders;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Medienart
2
Aufsätze
2
E-Artikel
2
E-Ressourcen
Zeitschriftentitel
2
WHO International Clinical Trials Registry Plat...
Thema
2
610
Medical Condition: We want to investigate wheth...
2
Recruitment Status: Not yet recruiting
2
Study Type: Interventional
Erscheinungszeitraum
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2
Englisch
Haven't found what you're looking for?
Wird geladen...